Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome

Clinical and Translational Medicine(2023)10.1002/ctm2.1327Source: DataRank Database

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome is a research paper published in Clinical and Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.09)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Miho Watanabe ORCID,Jun Liu ORCID,Kenji Tokunaga,Eisaku Iwanaga ORCID,Yoshihiro Komohara ORCID

Live enrichment

PubMed:37501279 PMC:PMC10374880 OpenAlex:https://openalex.org/W4385330391

National Institutes of Health

Grant: P01HL158688

NHLBI NIH HHS

Grant: P01 HL131477

NCI NIH HHS

Grant: R35 CA197697

National Institutes of Health

Grant: 5R35CA197697-05

Mechanisms of regulation by RNA in acute myeloid leukemia

National Institutes of Health

Grant: 5P01HL131477-05

Functional consequences of stem and progenitor cell heterogeneity

National Institutes of Health

Grant: 7P01HL158688-03

Novel Strategies to Improve Blood Transfusion Practice

FWCI

0.09

Citation Percentile

0.4%

Citation Trend

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.1327

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.1327

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1327

journalhttps://doi.org/10.1002/ctm2.1327

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37501279

Fields of Study

Renal and related cancersAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia research0301 basic medicine03 medical and health sciences

MeSH Terms

DNA-Binding ProteinsHumansMyelodysplastic SyndromesTranscription Factors

Keywords

Myelodysplastic syndromesGATA2MedicineCancer researchTranscription factorBone marrowInternational Prognostic Scoring SystemMyeloid leukemiaMyeloidHaematopoiesisLeukemiaDysplasiaMass cytometryStem cellBioinformaticsBiologyImmunologyGenePathologyGeneticsDNA-Binding ProteinsMedicine (General)R5-920HumansLetter to the EditorTranscription Factors